ACTIGEN Trademark

Trademark Overview


On Wednesday, February 8, 2023, a trademark application was filed for ACTIGEN with the United States Patent and Trademark Office. The USPTO has given the ACTIGEN trademark a serial number of 97785556. The federal status of this trademark filing is FIRST EXTENSION - GRANTED as of Monday, April 29, 2024. This trademark is owned by Sanara Medtech Inc.. The ACTIGEN trademark is filed in the Pharmaceutical Products category with the following description:

Human tissue allograft
actigen

General Information


Serial Number97785556
Word MarkACTIGEN
Filing DateWednesday, February 8, 2023
Status730 - FIRST EXTENSION - GRANTED
Status DateMonday, April 29, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements


Goods and ServicesHuman tissue allograft

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, February 17, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSanara Medtech Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFort Worth, TX 76102

Party NameSanara Medtech Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Worth, TX 76102

Trademark Events


Event DateEvent Description
Saturday, February 11, 2023NEW APPLICATION ENTERED
Friday, February 17, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, April 11, 2023ASSIGNED TO EXAMINER
Tuesday, April 11, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 6, 2023EXTENSION OF TIME TO OPPOSE RECEIVED
Tuesday, November 7, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, September 24, 2023EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, April 30, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, April 29, 2024SOU TEAS EXTENSION RECEIVED
Monday, April 29, 2024SOU EXTENSION 1 FILED
Monday, April 29, 2024SOU EXTENSION 1 GRANTED
Wednesday, September 18, 2024TEAS STATEMENT OF USE RECEIVED

Related Keywords


actigen allograft tissue human